CD274 and neoplasm: Although this score is obtained through immunohistochemical evaluation of the resected primary tumors, it might provide a summarized data about the tumor immunogenicity, its inhibitory immune checkpoint status, and the epigenetic potential of tumor cells in PD-L1 expression in individual patients.